TUCCI, MARCO GAETANO
 Distribuzione geografica
Continente #
NA - Nord America 10.550
AS - Asia 4.548
EU - Europa 4.035
SA - Sud America 1.135
AF - Africa 194
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.474
Nazione #
US - Stati Uniti d'America 10.346
SG - Singapore 1.904
IT - Italia 1.401
CN - Cina 913
BR - Brasile 861
HK - Hong Kong 581
SE - Svezia 507
RU - Federazione Russa 448
DE - Germania 360
VN - Vietnam 323
FR - Francia 293
FI - Finlandia 270
GB - Regno Unito 215
UA - Ucraina 196
IN - India 160
BD - Bangladesh 114
CA - Canada 108
ID - Indonesia 108
AR - Argentina 96
IQ - Iraq 62
ZA - Sudafrica 54
PL - Polonia 51
MX - Messico 46
NL - Olanda 46
BE - Belgio 45
PK - Pakistan 42
JP - Giappone 41
AT - Austria 40
CO - Colombia 40
EC - Ecuador 40
CI - Costa d'Avorio 39
TR - Turchia 37
CL - Cile 36
SA - Arabia Saudita 35
PH - Filippine 32
ES - Italia 28
MY - Malesia 27
LT - Lituania 26
MA - Marocco 24
IE - Irlanda 22
UZ - Uzbekistan 21
VE - Venezuela 21
KE - Kenya 19
JO - Giordania 18
NP - Nepal 18
TN - Tunisia 17
PY - Paraguay 15
CH - Svizzera 13
IR - Iran 12
CR - Costa Rica 11
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
JM - Giamaica 10
KR - Corea 10
AL - Albania 9
KZ - Kazakistan 9
OM - Oman 9
PE - Perù 9
GR - Grecia 8
UY - Uruguay 8
AU - Australia 7
EG - Egitto 7
ET - Etiopia 7
BO - Bolivia 6
HN - Honduras 6
IL - Israele 6
LB - Libano 6
DO - Repubblica Dominicana 5
GT - Guatemala 5
KG - Kirghizistan 5
LV - Lettonia 5
MK - Macedonia 5
PS - Palestinian Territory 5
PT - Portogallo 5
RO - Romania 5
RS - Serbia 5
SY - Repubblica araba siriana 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
HU - Ungheria 4
KW - Kuwait 4
SN - Senegal 4
TH - Thailandia 4
AM - Armenia 3
AO - Angola 3
BH - Bahrain 3
DZ - Algeria 3
HR - Croazia 3
NZ - Nuova Zelanda 3
PA - Panama 3
BB - Barbados 2
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
IS - Islanda 2
LY - Libia 2
MN - Mongolia 2
MR - Mauritania 2
NI - Nicaragua 2
Totale 20.436
Città #
Singapore 1.079
Ashburn 1.034
Fairfield 930
Chandler 700
Woodbridge 635
San Jose 587
Hong Kong 573
Milan 535
Jacksonville 431
Houston 422
Nyköping 407
Seattle 369
Cambridge 362
Beijing 315
Wilmington 301
Ann Arbor 269
Lauterbourg 176
Helsinki 168
New York 166
Lawrence 151
Roxbury 149
Dallas 147
Los Angeles 144
Rome 141
Nanjing 114
Des Moines 99
Bari 98
Santa Clara 94
Ho Chi Minh City 92
Boardman 84
São Paulo 82
Princeton 78
Jakarta 77
Council Bluffs 76
Brooklyn 73
Columbus 67
Falkenstein 67
Buffalo 61
Hanoi 61
Inglewood 61
Munich 59
Chicago 54
Figino 51
San Diego 48
Warsaw 46
Brussels 44
London 41
Nuremberg 41
Abidjan 39
Paris 36
Frankfurt am Main 35
Redwood City 33
Dong Ket 31
Montreal 30
Turin 29
North Bergen 27
Tokyo 27
Denver 26
Shenyang 26
Toronto 26
Phoenix 24
Rio de Janeiro 24
Chennai 23
Hebei 23
Nanchang 23
Dublin 22
Johannesburg 22
Naples 22
Orem 22
Stockholm 22
Baghdad 21
Mumbai 21
Atlanta 20
Dearborn 20
Salt Lake City 20
Belo Horizonte 19
Santiago 19
Tashkent 19
Amsterdam 18
Vienna 18
Dhaka 17
Moscow 17
Washington 17
New Delhi 16
Quito 16
Tianjin 16
Amman 15
Guangzhou 15
The Dalles 15
Bologna 14
Brasília 14
Cape Town 14
Curitiba 14
Da Nang 14
Marseille 14
Mexico City 14
Ottawa 14
Porto Alegre 14
San Mateo 14
Taranto 14
Totale 12.944
Nome #
Ruolo degli agonisti dei recettori sigma-2 nei fenomeni di farmacoresistenza associati alla chemioterapia nel mieloma multiplo 944
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). 332
Animal-type melanoma: Dog or wolf? A review of the literature and a case report 215
Adenocarcinoma of the ceruminous glands: role of the VMAT 196
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 196
The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine 196
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells. 195
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology 190
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. 183
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 180
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 179
Immune system and melanoma biology: A balance between immunosurveillance and immune escape 178
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 178
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 177
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 172
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 171
Avβ3 integrin: Pathogenetic role in osteotropic tumors 168
Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis 167
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 165
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 165
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications 162
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 158
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations 156
PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. 155
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 153
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. 152
Anemia in multiple myeloma: role of deregulated plasma cell apoptosis 149
Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis 149
Cytotherapies in multiple myeloma: a complementary approach to current treatments 149
Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis 147
An update on Merkel cell carcinoma 146
Does cilengitide deserve another chance? 144
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma 144
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 143
The clonal heterogenicity of circulating tumor cells (CTCs) drives their metastatic potential: a new NOD‐SCID melanoma model 142
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice 142
Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle 141
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 139
Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now? 139
A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression. 138
Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus 136
Successful treatment with apremilast of severe psoriasis exacerbation during nivolumab therapy for metastatic melanoma 135
Recent advances in understanding the pathogenesis of anemia in multiple myeloma 133
AlphaVBeta3+ (AvB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 132
Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease 130
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 130
Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro 129
DLC-1 down-regulation via exosomal miR-106b-3p exchange promotes CRC metastasis by the epithelial-to-mesenchymal transition 128
Alpha(V)Beta(3) (alpha(v)beta(3)) integrin drives the osteoclastogenesis through a osteoclast-like functional differentiation of myeloma cells 126
SNPs in predicting clinical efficacy and toxicity of chemotherapy: Walking through the quicksand 126
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma 126
Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupus 125
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors. 125
A functional polymorphism in the monocyte chemoattractant protein (MCP) - 1 promoter gene is strongly associated with lupus nephritis 124
Large extracellular vesicles—a new frontier of liquid biopsy in oncology 124
A new tool for the evaluation of disease activity in lupus nephritis: Urinary monocyte chemoattractant protein (MCP)-1. 123
Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer 123
[Malignant neoplasms and AIDS. Review of the literature and critical considerations on a case of epidermoid carcinoma of the anus]. FT Neoplasie maligne e AIDS. Rassegna della letteratura e considerazioni critiche su un caso di carcinoma epidermoide dell'ano. 122
The day after mass COVID-19 vaccination: incidence of vaccine-related lymphadenopathy PET and impact on oncologic patients management 122
Severe anemia in a patient with vulvar melanoma 121
Negative regulation of erythroblast maturation by Fas-L+/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma 120
Massive hyper-progression during anti-PD1 immunotherapy in a young patient with metastatic mucinous adenocarcinoma of the right colon: a case report and literature review 120
miRNAs in melanoma: a defined role in tumor progression and metastasis 119
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer 118
A functional polymorphism in the monocyte chemoattractant protein (MCP)-1 promoter gene is strongly associated with lupus nephritis 118
Nef protein induces differential effects in CD8+ cells from HIV-1-infected patients 118
Induction of apoptosis by the hydrocarbon oil pristane: Implications for pristane-induced lupus 117
Antiphosphatidylserine antibodies in human immunodeficiency virus-1 patients with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity 116
A role for fas-ligand in the pathogenesis and progression of multiple myeloma(MM). 115
Prognostic factors and current treatment strategies for renal cell carcinoma metastatic to the brain: An overview 114
The immune escape in melanoma: role of the impaired dendritic cell function 113
Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation 113
Erratum for Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). 113
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer 113
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients. 112
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 110
Antiphosphatidylserine antibodies in human immunodeficiency virus-1(+) patients correlate with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity 110
Checkpoint Inhibitor-Induced Colitis: An Update 108
Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice 108
Dendritic Cells and Malignant Plasma Cells: An Alliance in Multiple Myeloma Tumor Progression? 107
Is measurement of IL-10 useful for disease management in SLE? 106
Alphavbeta3 (AVB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 106
Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis 106
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey. 106
Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression 105
Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia 103
null 103
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 101
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells 101
Immunomodulation of T and B cell functions in multiple myeloma patients treated with combined erythropoietin and α-interferon therapy 101
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 101
Increased IL-18 production by dendritic cells in active inflammatory myopathies 100
Mast cells positive to c-kit receptor and to tryptase in normal to cancer pancreatic tissue and the correlation with angiogenesis. 100
Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia 99
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients 99
Biliary tract cancers: moving from the present standards of care towards the use of immune checkpoint inhibitors 98
Non-Melanoma Skin Cancers: Biological and Clinical Features 97
Vasculiti primarie sistemiche 96
Bone metastases in soft tissue sarcoma patients: a survey of natural, prognostic value and treatment 96
The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis 96
Totale 14.337
Categoria #
all - tutte 89.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.108 63 139 16 57 55 80 37 53 75 83 193 257
2022/20231.888 284 222 124 159 193 253 37 231 297 17 45 26
2023/2024680 62 127 41 102 64 114 20 33 9 18 15 75
2024/20253.310 134 38 285 160 95 271 336 288 172 216 427 888
2025/20268.654 1.055 341 448 776 801 442 848 246 896 736 1.158 907
2026/2027203 203 0 0 0 0 0 0 0 0 0 0 0
Totale 21.110